Singapore - GSK
GSK was the first global healthcare company to establish a presence in Singapore in 1959. For over 60 years, GSK has been an important contributor to the healthcare system and the biopharma manufacturing sector in Singapore.
GSK today celebrated the groundbreaking of its S$343 million state-of-the-art vaccines facility at Tuas which will manufacture drug substances for GSK’s vaccines that protect against Hepatitis B. This expansion of the existing GSK facility at Tuas will start construction in the third quarter of 2023, with completion targeted by 2025.
GSK’s Tuas vaccine facility is Singapore’s largest after S$300 …
Jul 13, 2023 · THE expansion of British drugmaker GSK’s facility at Tuas has earned it the title of Singapore’s largest vaccine production site based on a cumulative investment of some S$850 million, said Minister for Trade and Industry Gan Kim Yong.
GSK’s Tuas vaccine facility is Singapore’s largest after over $300m ...
Nov 18, 2024 · SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative investment of some $850 million,...
GSK invests S$343 million in state-of-the-art vaccines facility ...
Global biopharmaceutical powerhouse GSK is expanding its Tuas vaccines facility in Singapore and will begin producing drug substances for Hepatitis B vaccines when commercial production commences in 2027.
GSK announces major new commitment to Asia
GlaxoSmithKline (GSK) is strengthening its presence in Singapore by establishing a new global headquarters for Asia; further expanding its commitment to patients and consumers in the region, the company announced today.
GSK debuts new $33M high-potency Singapore plant focused on …
Nov 17, 2022 · GSK continues to grow its manufacturing footprint in Singapore with the opening of a new 44 million Singapore dollar ($33 million) (PDF) plant that will be focused on producing key ingredients...
GSK opens first-in-Singapore high potency manufacturing and …
The opening of GSK’s new facility demonstrates how global healthcare companies can tap on Singapore’s world-class infrastructure and talent to deliver innovative new products.
GSK opens first high-potency facility in Singapore to produce …
Nov 17, 2022 · SINGAPORE - GSK officially opened its first high-potency manufacturing and test facility in Singapore on Thursday, with the capability to manufacture highly potent components for cancer...
GSK opens $95M continuous production operation in Singapore
Jul 8, 2019 · A continuous manufacturing facility championed by former GlaxoSmithKline CEO Andrew Witty has just opened in Singapore, marking a new milestone in the manufacturing of the drugmaker. GSK says...